skip to Main Content
How To Build A Successful Direct-to-Consumer GLP-1 Prescription Program

How to Build a Successful Direct-to-Consumer GLP-1 Prescription Program

GLP-1 medications are revolutionizing the modern approach to weight management, offering a promising solution for individuals struggling with obesity. With their proven efficacy in promoting weight loss and managing blood sugar levels, GLP-1 treatments have seen a significant surge in demand. In fact, the GLP-1 market was valued at $16.53 billion in 2021 and is expected to reach a whopping $24.10 billion by 2027.1 

For healthcare organizations and businesses, this presents a unique opportunity to get ahead of the curve by implementing a direct-to-consumer GLP-1 prescription program. Here’s how leveraging WellSync’s offerings can streamline this process, providing a fast, efficient, and patient-centric service.

The Rise of GLP-1 Medication

GLP-1-medication

GLP-1 (Glucagon-like peptide-1) medications have transformed the landscape of weight loss treatment. Unlike traditional methods like diet and exercise, which can be lengthy and ineffective for some, GLP-1 therapies take a medical approach. They work by mimicking a natural hormone that regulates appetite and food intake, leading to significant weight loss and improved glycemic control.

The current market surge is driven by the effectiveness of these medications and the growing need for innovative obesity treatments. 

Clinical Efficacy

In a two-year trial, participants receiving semaglutide experienced a mean weight loss of 15.2% from baseline, with over 75% losing ≥5% of their initial weight.2 This level of weight reduction is considered clinically meaningful and surpasses results from similar pharmacotherapies for weight management. 

Capitalizing on the GLP-1 Market Surge with WellSync

To capitalize on this growing demand, businesses need a robust, scalable solution that can adapt to the fast-evolving healthcare landscape. WellSync’s white-labeled technology platform offers a seamless way to launch and manage a GLP-1 prescription program tailored to your brand and patient needs.

Fast Start-up Times

Our white-labeled technology is designed for quick deployment, allowing your organization to roll out a GLP-1 prescription program in record time. This agility ensures you can meet patient demand without delay, setting you apart in a competitive market.

Seamless Integration Into Your Site

WellSync’s technology seamlessly integrates into your existing website, enabling you to offer a full suite of GLP-1 services directly to your consumers. From initial consults to prescribing meds and ordering labs, our platform ensures a smooth, end-to-end service that keeps patients engaged and retained within your ecosystem.

Synchronous and Asynchronous Care

Sync and Async Telemedicine

WellSync supports both synchronous (real-time) and asynchronous (time-delayed) telehealth services. This dual approach allows patients to choose the communication method that best suits their lifestyle and preferences, enhancing the patient experience. Synchronous care offers immediate, real-time consultations, while asynchronous care provides flexibility for patients to communicate their health information at their convenience.

Access to a Telehealth Provider Network

Launching a GLP-1 program requires access to qualified healthcare providers who can prescribe and manage these treatments. WellSync grants you access to an extensive network of telehealth providers, ensuring that patients always receive care from experienced professionals.

Mail-order Pharmacy Fulfillment

To complete the circle of care, WellSync integrates mail-order pharmacy fulfillment into the GLP-1 prescription program. This integration ensures that patients receive their medications promptly and conveniently, directly to their doorstep. Mail-order fulfillment not only adds to the convenience but also supports medication adherence by simplifying the refill process.

Build Your Program with WellSync in 3 Easy Steps

1. Add Our CareHub to Your Site

Integrate WellSync’s CareHub directly into your website with ease. This first step transforms your digital space into a fully functional telehealth service portal, ready to offer GLP-1 weight loss programs to your customers.

2. Start Driving Traffic

With our CareHub integrated, begin directing your existing and new traffic to your telehealth offerings. Utilize your marketing channels to highlight the availability of a GLP-1 weight loss program right on your site, encouraging users to take the first step toward their health goals.

3. We Take Care of the Rest

Once your customers sign up, they’re in good hands. WellSync’s network of qualified clinicians will conduct consultations, manage treatments, and oversee patient care. Simultaneously, our affiliated pharmacies will ensure timely delivery of GLP-1 medications directly to your customers’ homes.

Get Started Today

As the demand for GLP-1 medications continues to grow, now is the time to explore how a direct-to-consumer prescription program can enhance your service offerings and meet the evolving needs of your patients. With WellSync, you have a partner ready to support you every step of the way, from initial setup to ongoing management and scaling.

Sources:

  1. Global Glucagon-like Peptide 1 (GLP-1) Market Analysis Report 2023: Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH Gaining Momentum.” GlobeNewswire, January 30, 2023. https://www.globenewswire.com 
  2. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.” Nature Medicine, October 10, 2022. Nature.com. https://www.nature.com/articles/s41591-022-02026-4 
Back To Top